WELLVONE 750 mg/5 ml, oral suspension bottle, 226 ml
Active ingredients: Atovaquone
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 226 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- WELLVONE 750 mg/5 ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 226 ml avec fermeture de sécurité avec cuillère-mesure polypropylène
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Mar 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66955317CIP73657278CIP133400936572782Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATOVAQUONEsuspension | 750 mg · une cuillère mesure de 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.